References
- Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thrombo-embolism. J Am Med Assoc 1999;282:2003–11.
- Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with DOT 10.1080/02841850410008324 © 2004 Taylor & Francis better outcome: the NINDS rt-PA Stroke Study. Neurology 2002;55: 1649–55.
- Qureshi Al, Siddiqui AM, Sun i MF, Kim SH, All Z, Yahia AM, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neuro-surgery 2002;51:1319–27.
- Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty. Am J Neuroradiol 1997;18: 1661–8.
- Tomsick T, Brott T, Barsan W, Broderick J, Haley EC, Spilker J, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra early thrombolytic therapy. Am J Neuroradiol 1996;17: 79–85.
- Yoneyama T, Nakano S, Kawano H, Iseda T, Ikeda T, Goya T, et al. Combined direct percutaneous translum-inal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. Am J Neuroradiol 2002;23:277–81.